Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)
Small Molecules Studied
Download: Excel (XLSX), Comma-separated (CSV), Images (Zip file)
| HMS LINCS ID | Name | Alternative Names | LINCS ID | Structure Image | PubChem CID |
|---|---|---|---|---|---|
| 10283-1 | XRP44X | AG-G-87906 | LSM-4298 |  | 10339779 |
| 10282-1 | Vorinostat | suberoylanilide hydroxamic acid (SAHA); Zolinza | LSM-3828 |  | 5311 |
| 10281-1 | Vinorelbine | Navelbine | LSM-6302 |  | 5311497 |
| 10280-1 | Triciribine | LSM-3810 |  | 65399 | |
| 10279-1 | Trichostatin A | LSM-43005 |  | ||
| 10278-1 | Topotecan | Hycamtin | LSM-5662 |  | 60700 |
| 10277-1 | Temsirolimus | LSM-4295 |  | 148191 | |
| 10276-1 | TCS 2312 | LSM-6362 |  | 11258443 | |
| 10275-1 | (Z)-4-Hydroxytamoxifen | LSM-43294 |  | 53770298 | |
| 10274-1 | SB-3CT | LSM-4293 |  | 9883002 | |
| 10273-1 | Purvalanol A | LSM-3118 |  | 456214 | |
| 10272-1 | Pemetrexed | Alimta | LSM-6353 |  | 446556 |
| 10271-2 | PD 98059 | LSM-3394 |  | 4713 | |
| 10270-1 | Oxamflatin | LSM-4290 |  | 4611 | |
| 10269-1 | Oxaliplatin | Eloxatin | LSM-44941 |  | 5310940 |
| 10268-1 | Nutlin 3a | LSM-6351 |  | 11433190 | |
| 10267-1 | NU6102 | LSM-4287 |  | 4566 | |
| 10266-1 | NSC 663284 | LSM-2042 |  | 379077 | |
| 10265-1 | Pevonedistat | MLN 4924; MLN-4924; MLN4924 | LSM-6263 |  | 16720766 |
| 10264-1 | Methotrexate | Rheumatrex; Trexall; Amethopterin; MTX | LSM-5690 |  | 126941 |
| 10263-1 | LBH589 | Panobinostat | LSM-4284 |  | 57519507 |
| 10262-1 | L-779450 | LSM-4283 |  | 9950176 | |
| 10261-1 | Ixabepilone | Azaepothilone B; Ixempra | LSM-43293 |  | 216344 |
| 10260-1 | Ispinesib | SB-715992 | LSM-5732 |  | 6851740 |
| 10259-1 | ICRF-193 | LSM-4280 |  | 115150 |